EPS15 Antikörper (C-Term)
Kurzübersicht für EPS15 Antikörper (C-Term) (ABIN631791)
Target
Alle EPS15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- EPS15 antibody was raised against the C terminal of EPS15
-
Aufreinigung
- Affinity purified
-
Immunogen
- EPS15 antibody was raised using the C terminal of EPS15 corresponding to a region with amino acids LDSPDPFKLNDPFQPFPGNDSPKEKDPEIFCDPFTSATTTTNKEADPSNF
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
EPS15 Blocking Peptide, (ABIN940254), is also available for use as a blocking control in assays to test for specificity of this EPS15 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EPS15 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EPS15 (Epidermal Growth Factor Receptor Pathway Substrate 15 (EPS15))
-
Andere Bezeichnung
- EPS15
-
Hintergrund
- EPS15 is a protein that is part of the EGFR pathway. The protein is present at clatherin-coated pits and is involved in receptor-mediated endocytosis of EGF. Notably, this gene is rearranged with the HRX/ALL/MLL gene in acute myelogeneous leukemias.
-
Molekulargewicht
- 99 kDa (MW of target protein)
-
Pathways
- EGFR Signaling Pathway, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, EGFR Downregulation
Target
-